|
|
|
|
| LEADER |
01000caa a22002652 4500 |
| 001 |
OLC1882515803 |
| 003 |
DE-627 |
| 005 |
20230511060652.0 |
| 007 |
tu |
| 008 |
111115s2011 xx ||||| 00| ||und c |
| 028 |
5 |
2 |
|a sw111112_1
|
| 035 |
|
|
|a (DE-627)OLC1882515803
|
| 035 |
|
|
|a (DE-599)GBVOLC1882515803
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 082 |
0 |
4 |
|a 570
|a 610
|
| 084 |
|
|
|a PHARM
|2 fid
|
| 084 |
|
|
|a XA 24552
|q AVZ
|2 rvk
|
| 084 |
|
|
|a 44.38
|2 bkl
|
| 084 |
|
|
|a 44.43
|2 bkl
|
| 084 |
|
|
|a 44.40
|2 bkl
|
| 100 |
1 |
|
|a Patel, Kashyap
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Population Pharmacokinetics of Fluconazole in Critically Ill Patients Receiving Continuous Venovenous Hemodiafiltration: Using Monte Carlo Simulations To Predict Doses for Specified Pharmacodynamic Targets
|
| 264 |
|
1 |
|c 2011
|
| 300 |
|
|
|a 6
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 700 |
1 |
|
|a Roberts, Jason A.
|4 oth
|
| 700 |
1 |
|
|a Lipman, Jeffrey
|4 oth
|
| 700 |
1 |
|
|a Tett, Susan E.
|4 oth
|
| 700 |
1 |
|
|a Deldot, Megan E.
|4 oth
|
| 700 |
1 |
|
|a Kirkpatrick, Carl M.
|4 oth
|
| 773 |
0 |
8 |
|i Enthalten in
|t Antimicrobial agents and chemotherapy
|d Washington, DC : American Society for Microbiology, 1962
|g 55(2011), 12 vom: Dez., Seite 5868-5874
|w (DE-627)129542318
|w (DE-600)217602-6
|w (DE-576)01499142X
|x 0066-4804
|7 nnns
|
| 773 |
1 |
8 |
|g volume:55
|g year:2011
|g number:12
|g month:12
|g pages:5868-5874
|g extent:6
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_OLC
|
| 912 |
|
|
|a FID-PHARM
|
| 912 |
|
|
|a SSG-OLC-PHA
|
| 912 |
|
|
|a SSG-OLC-DE-84
|
| 912 |
|
|
|a SSG-OPC-PHA
|
| 912 |
|
|
|a GBV_ILN_20
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_62
|
| 912 |
|
|
|a GBV_ILN_2006
|
| 912 |
|
|
|a GBV_ILN_4012
|
| 912 |
|
|
|a GBV_ILN_4112
|
| 912 |
|
|
|a GBV_ILN_4219
|
| 912 |
|
|
|a GBV_ILN_4305
|
| 936 |
r |
v |
|a XA 24552
|
| 936 |
b |
k |
|a 44.38
|q AVZ
|
| 936 |
b |
k |
|a 44.43
|q AVZ
|
| 936 |
b |
k |
|a 44.40
|q AVZ
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 55
|j 2011
|e 12
|c 12
|h 5868-5874
|g 6
|
